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Abstract
Tendon and ligaments have poor healing capacity and when injured often require surgical intervention. Tissue
replacement via autografts and allografts are non-ideal strategies that can lead to future problems. As an alterna-
tive, scaffold-based tissue engineering strategies are being pursued. In this review, we describe design considera-
tions and major recent advancements of scaffolds for tendon/ligament engineering. Specifically, we outline native
tendon/ligament characteristics critical for design parameters and outcome measures, and introduce synthetic and
naturally-derived biomaterials used in tendon/ligament scaffolds. We will describe applications of these biomaterials
in advanced tendon/ligament engineering strategies including the utility of scaffold functionalization, cyclic strain,
growth factors, and interface considerations. The goal of this review is to compile and interpret the important find-
ings of recent tendon/ligament engineering research in an effort towards the advancement of regenerative
strategies.
Review
The primary role of tendon and ligament is to transfer
forces between musculoskeletal tissues. Adult tendon
and ligament have relatively low oxygen and nutrient
requirements, low cell density, and poor regenerative
capacity, yet they experience some of the highest
mechanical loads in the body. When these loads exceed
a critical threshold that causes permanent tissue
damage, impaired function and mobility will result. For
the repair of both tissues, given their very low self-
regenerative capacity, typically the only recourse is sur-
gical intervention. Current surgical reparative techniques
rely on tissue replacement with auto- or allografts, and
are often accompanied with additional problems such as
donor site morbidity, pain and graft failure. A more
ideal solution would be to fully restore the tendon or
ligament tissue to its pre-injured state. This is the pro-
mise of tissue engineering, a field which aims to incor-
porate specific cell types into a biodegradable scaffold
which when implanted will gradually regenerate into a
tissue that closely resembles the original tissue and
restores functionality. In this review, we outline the
state of the art of tendon and ligament (T/L) tissue
engineering. Relatively little is known about these tissues
as compared to other musculoskeletal tissues such as
bone, cartilage and muscle, though recent studies have
made significant advances, and distinct biological differ-
ences between tendon and ligament are beginning to be
recognized [1-3]. However, from an engineering stand-
point these tissues are functionally similar, and thus as
reviewed here, tissue engineering efforts commonly refer
to these tissues interchangeably. This review will discuss
biomaterial selection and functionalization, scaffold
design, cellular activities critical for tissue function, and
recent outcomes of long-term implantation studies in
animal models.
Native tendon and ligament macromolecular composition
and microenvironment
T/L properties that tissue engineers often try to mimic
are the biochemical composition and structure, cell
population, and mechanical properties of a native tissue.
T/L obtain their tensile strength and elasticity from the
molecular building block of their structure: triple-helical
type I collagen molecules. A dimensional hierarchy
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exists where collagen molecules (~1 nm diameter) orga-
nize into parallel nanoscale fibrils, and subsequently into
microscale fibers, both highly aligned along the major
axis of the T/L unit. Fibril diameters range from 50-
100 nm during embryonic development [4] and can
reach as large as 280 nm in adults [5], and show a char-
acteristic 67 nm lateral D-banding pattern coincident
with molecular gaps [6]. Collagen type I fibrils account
for the majority (~60%) of T/L dry mass and are sur-
rounded by other proteins, including collagen types III,
IV, V, and VI, and small-leucine rich proteins (SLRPs),
such as decorin and cartilage oligomeric matrix protein
(COMP), amongst others [7,8]. The functions of these
matrix proteins are to permit gliding of fibril bundles
and viscoelastic responses to load, provide secondary
crosslinking, assist with collagen fibril organization, and
provide space for proprioceptive neural networks and
vascular supply. One of the largest molecular differences
between tendons and ligaments is their elastin content;
human tendon is 2% elastin (dry wt.) [1], but in liga-
ment can range between 5%, 7.3% or 47% (dry wt.) in
the human anterior cruciate ligament [9], posterior
longitudinal ligament [2] and ligamentum flavum [10],
respectively. Another difference is that tendon may have
up to 34% higher pyridinoline content, a mature col-
lagen crosslinker, compared to ligament (normalized to
collagen content) [3].
T/L cells are circumferentially oriented around col-
lagen fibers and are responsible for maintaining the den-
sity and composition of the T/L matrix. By convention,
fibroblastic cells in tendon are known as “tenocytes”,
whereas in ligament they are known as “ligament fibro-
blasts”. T/L cells communicate with each other using
extended cell processes that terminate in connexin 32
and 43-positive gap junctions [11], and have a small
multipotent stem cell population [12]. In areas of high
compressive force, such as in wrap-around tendons or
near a bone insertion (enthesis), fibrocartilage cells are
also present [13]. Although gene-based identification of
T/L cells is currently incomplete, promising markers of
T/L cells include the transcription factor scleraxis (Scx)
[14], the transmembrane protein tenomodulin (Tnmd)
[15], and the extracellular matrix (ECM) glycoprotein
tenascin-C (TN-C) [16]. Unfortunately, these cell popu-
lations show very poor healing efficacy in vivo; animal
models have demonstrated that the mechanical proper-
ties of injured T/L are not recovered even after
12 months of healing [17].
The mechanical properties of T/L are highly complex
and unique owing to their hierarchical structures and
complex protein compositions. The normal response to
load is non-linear, anisotropic, and viscoelastic, showing
over 50% stress relaxation in 120 min [18]. Elastic mod-
uli of adult human Achilles tendon measured in vitro
have been found to be between 0.8-1.5 GPa [19], which
is comparable and slightly higher than in vivo ultra-
sound and reaction force-plate measurements at 0.87 ±
0.2 GPa [20] or 1.16 ± 0.15 GPa [21]. In vivo peak bulk
tissue strains in these studies have been estimated to be
8.3 ± 2.1% [20] with 18% hysteresis [21]. These proper-
ties are not comparable to cadaver Achilles or patellar
tendon, which typically have elastic moduli between
200-270 MPa [22]. Although no material can accurately
match the stiffness, ductility, non-linearity, and viscoe-
lastic response of native tendon, one of the major goals
of T/L engineering is to combine the appropriate bio-
degradable scaffold with cells and cellular cues to induce
ECM remodelling that closely matches the mechanical
properties and biochemistry of native tendon. Research-
ers have investigated both natural and synthetic bioma-
terials, in conjunction with many cell types, for this
purpose.
Synthetic biomaterials in tendon and ligament tissue
engineering
An ideal engineered T/L would contain enough starting
biomaterial for immediate load bearing post-implanta-
tion, and would degrade at a rate comparable with that of
developing cellular and tissue in-growth. After a period
of several weeks or months the starting material, or scaf-
fold, would be completely replaced by regenerating T/L
cells and matrix. The requirement for biodegradability
and fabrication into specific tendon- and ligament-like
geometries has generated interest in the use of synthetic
polymer materials for T/L tissue engineering [23].
Polyhydroxyesters degrade by hydrolysis and thus have
been very popular for T/L tissue engineering. An early
cell attachment study found that anterior cruiciate liga-
ment (ACL)-derived fibroblasts adhered and proliferated
on poly(ε-caprolactone) (PCL), PCL/poly(DL-lactide)
(PLA) (50:50), and poly(DL-lactide-co-glycolide) (PLGA)
(50:50) two-dimensional substrates at a rate that was
not significantly less than tissue-culture plastic [24].
Composites of these materials are often fabricated to tai-
lor degradation rates and optimize surface energies since
high hydrophilicity is thought to be detrimental to cell
adhesion [25]. Several studies have built upon these ear-
lier findings and extended T/L cell culture into three
dimensions (3D) with polyhydroxyester scaffolds.
Lu et al. [26] fabricated 3D braided scaffolds of PGA,
PLGA, and poly(L-lactic acid) (PLLA) filaments at two
levels of bundling using a circular braiding loom
designed to mimic the hierarchical structure of native
ligament. Scaffolds were immersed in a solution of
human recombinant fibronectin (Fn) to improve cell
adhesion. After 14 days of culture with rabbit ACL
fibroblasts, scanning electron microscopy (SEM) analysis
found that cells seeded on PLLA-Fn and PLGA-Fn
Kuo et al. Sports Medicine, Arthroscopy, Rehabilitation, Therapy & Technology 2010, 2:20
http://www.smarttjournal.com/content/2/1/20
Page 2 of 14
scaffolds produced the most matrix, and that PGA was
detrimental to matrix formation, thought to be from
rapidly produced acidic byproducts (Fig. 1).
Interestingly, PGA-Fn had significantly reduced cell
numbers compared to PLGA-Fn and PLLA-Fn scaffolds
(p < 0.05), the latter two being not significantly different
from each other (p > 0.05) [26]. The authors concluded
that while both the PLLA-Fn and PLGA-Fn scaffolds
would be effective for ligament tissue engineering, that
the PLLA-Fn scaffolds may be the more appropriate
choice due to their slower degradation rate. A study of
the tensile properties of braided PLGA 10:90 scaffolds
found ultimate tensile strengths between 100-400 MPa,
and with a circular braiding scheme, a maximum load
of over 900 N, both of which were considered practical
and safe for initial implantation in a human ACL repla-
cement surgery [27]. Recent work has also elucidated
ideal braiding angles of these scaffolds (60-72°) to more
accurately mimic the non-linear stress-strain relation-
ship of native T/L [28]. Taken together, these studies
show great promise for future use of braided PLGA
scaffolds for T/L replacement, particularly if the degra-
dation profiles are optimally balanced against tissue
ingrowth using an animal model.
Synthetic PLGA 10:90 scaffolds have also been co-fab-
ricated with biopolymers such as collagen type I to form
porous, rolled microsponges, to combine mechanical
strength and cellular binding affinity for T/L tissue engi-
neering [29]. To fabricate the microsponges, PLGA was
immersed in a solution of bovine collagen type I, freeze-
dried and crosslinked with glutaraldehyde. Canine ACL
fibroblasts were cultured on the scaffolds for 16 days
in vitro before rolling and subcutaneous implantation in
nude mice. Using hematoxylin and eosin (H&E) stain-
ing, coupled with SEM analysis, the authors found that
cells were viable and produced a uniform matrix in the
scaffold center even after 12 weeks of implantation. This
was a very encouraging result since the scaffolds had
millimeter-scale diameters, much greater than the oft-
cited O2 diffusion limit of 200-300 μm.
One of the advantages of synthetic polymers is that
they can be processed relatively easily into fibers with
nanometer-scale diameters - on the order of native col-
lagen fibrils - using electrospinning [30]. Lee et al. [31]
produced aligned polyurethane (PU) nanofiber scaffolds
with average fiber diameter of 650 nm and 82% porosity
using an electrospinning apparatus and a rotating collec-
tor target. Seeded human ligament cells were cultured
for 48 hours then subjected to 5% uniaxial strain at
0.083 Hz using vacuum flexion on a silicone membrane
for an additional 24 hours. Aligned scaffolds produced
significantly more collagen mass (per DNA mass) com-
pared to randomly oriented scaffolds (p < 0.05), and
aligned scaffolds showed cell morphologies that better
resembled in vivo morphology. This study was one of
several demonstrating the superiority of aligned, as
opposed to random, nanofiber orientations for T/L tis-
sue engineering. Composite nano- and micro-fiber scaf-
folds have also been fabricated for T/L tissue
engineering [32]. In this study electrospun PLGA (65:35)
nanofibers (300-900 nm dia.) were deposited onto a
mesh of 25 μm diameter PLGA (10:90) microfibers
resulting in ~2-50 μm pores. The rationale for this sys-
tem was that the microfibers would provide mechanical
Figure 1 ACL fibroblast growth and matrix formation on different synthetic braided scaffolds visualized with SEM [26]. Images were
taken after 14 days of in vitro culture in 10% fetal bovine serum. (Left) Culture with PGA resulted in substantial matrix degradation from acidic
byproducts. (Middle) PLA and PGA in a 82:18 mass ratio showed more sustainable matrix formation, particularly with the addition of fibronectin
(Fn). (Right) PLLA scaffolds also displayed considerable matrix formation, which again was amplified by the addition of Fn. Reproduced with
permission from Elsevier B.V.
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strength and degradation resistance, and the nanofibers
would provide hydrophilicity and a very high surface
area for cell attachment. The authors seeded porcine
bone-marrow derived mesenchymal stem cells (BMSCs)
and measured an average collagen production of 1.55
ng/cell after 7 days which was considered a high level of
matrix production relative to other scaffold geometries.
Furthermore, mRNA expression levels of relevant T/L
genes, such as collagen type I, decorin, and biglycan
(relative to the GAPDH), were all slightly upregulated
(5-20%), suggesting partial differentiation into T/L
lineages. A follow-up study reports further optimization
of these scaffolds including enhanced cell attachment
and proliferation using PCL and collagen type I surface
deposition, and also a ~50% increased failure load by
incorporating a right-angle fiber weaving method [33].
These studies and others [34,35] demonstrate some of
the advantages imparted by synthetic nanofiber technol-
ogies for T/L tissue engineering, which will continue to
expand and evolve as more specific T/L cell-nanofiber
interactions are elucidated. At present, it appears that
most studies show results favoring aligned nanofibers
over randomly oriented fibers, likely due to their resem-
blance to native T/L fibril orientation, but the ideal fiber
materials, diameters, spacing, and angles remain unre-
solved for T/L tissue engineering. Although single mate-
rials are often used, one promising strategy may to be
incorporate fibers of different diameters and mechanical
properties into a single aligned scaffold in an effort to
mimic the multi-protein matrix of T/L, e.g. collagen
type I, collagen type III, elastin, and proteoglycans. The
rapid degradation rate of synthetic nanofibers must also
be controlled and perhaps decelerated before in vivo
implantation will be feasible. Overall, however, current
synthetic nanofiber scaffolds are cytocompatible and
have tailorable diameters and degrees of alignment, and
are one of the most exciting prospects for the design of
engineered T/L tissues.
Natural polymeric biomaterials in tendon and ligament
tissue engineering
We have seen that synthetic polymeric biomaterials have
reproducible mechanical and chemical properties, are
easily fabricated into different shapes and sizes, can
degrade by hydrolysis, and are efficacious for T/L engi-
neering research. However, they may lack functional
chemical groups for cellular binding, and furthermore
they may release acidic byproducts or unnatural polye-
sters into the bloodstream during degradation. For these
reasons there has been considerable interest in the
application of natural, protein-based fiber materials as
scaffolds for T/L tissue engineering [36-40]. The most
direct and obvious choice for this material is collagen
type I because of its prevalence in T/L tissues.
Unfortunately, no method yet exists to organize and
crosslink collagen fibers in a cytocompatible manner,
and as such collagen gels remain exceptionally weak
with typical elastic moduli between 10-30 kPa and ulti-
mate tensile strengths between 5-10 kPa [41]. Thus col-
lagen-based scaffolds, while useful to investigate
mechanisms of tendon differentiation and regeneration
[42] and the effects of mechanical stimulation [43,44], at
present are limited for T/L replacement.
Silk fibroin, rather than collagen, is a popular natural
polymeric biomaterial used for T/L tissue engineering. Silk
fibroin is one of two proteins excreted by Bombyx mori
silkworms during cocoon production and is typically iso-
lated from its sister protein sericin using sodium carbo-
nate, urea, and/or detergents, and near-boiling
temperatures [45]. B. mori silk fibroin is 70-80% by mass
of the silk bicomplex [46], contains a heavy (350 kDa) and
light chain unit (25 kDa), and is held together by the sticky
cytotoxic sericin protein. The principal advantage of silk is
its remarkable tensile strength and toughness (area under
stress-strain curve) which is unmatched for natural pro-
teins. Reported tensile mechanical properties of B. Mori
silk fibroin range between 5-9 GPa for elastic modulus,
250-400 MPa for tensile strength, and 23-26% for failure
strain [47]. The protein also displays surface amino acids
for cell adhesion, remains structurally whole in aqueous
solutions but slowly degrades (weeks-months) proteolyti-
cally in vivo [48,49], and can be fabricated into gels, films,
braided fibers or nanofibers. These characteristics make
silk fibroin one of the best natural polymers for support of
cellular and tissue ingrowth for T/L tissue engineering.
Altman et al. were the first to design and test a
braided silk fibroin scaffold seeded with bMSCs for
T/L engineering [50]. A braided geometry with four
levels of bundles twisted with 0.5 cm pitch was chosen
to effectively reduce the stiffness of a single fiber to
better mimic native ACL mechanical properties. A fati-
gue analysis with a 400 N cyclic load indicated a
matrix life (after linear extrapolation) of 3.3 million
cycles, expected to far outlast in vivo degradation.
After 14 days of in vitro culture with human bMSCs,
the authors found that cell number increased 5-fold,
and that considerable matrix had been deposited.
Furthermore, mRNA analysis demonstrated expression
levels of T/L genes that were comparable to those in
native human ACLs, such as an average collagen type I
to type III ratio of ~9, an absence of collagen type II
and bone sialoprotein (which would indicate cartilage
or bone differentiation, respectively), and baseline
expression of the T/L marker tenascin-C. The success
of this initial work was considerable and highlighted
the potential applicability of silk fibroin that has been
properly processed and organized for in vivo T/L
replacement.
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Scaffold geometries other than braided structures have
also been fabricated with silk fibroin. Liu et al. [51] sur-
mised from previous studies of synthetic braided liga-
ments that such braided structures may have limited
nutrient diffusion and tissue infiltration, particularly
towards the center of the radial axis. To circumvent this
potential issue, the authors fabricated a silk fibroin hybrid
scaffold with geometries at two levels: a knitted scaffold
and an interspersed microporous silk sponge. The knitted
scaffold was fabricated using a 40-needle knitting
machine, and the sponge was added by immersing the
knitted scaffold in a low concentration silk solution,
freeze drying to form pores, and then immersing in a
methanol solution to prevent resolubilization. Compared
with knitted scaffolds alone after 14 days of hMSC cul-
ture, the knitted-sponge scaffolds showed significantly
higher biological responses with nearly every evaluation
method (p < 0.05), including cellular proliferation, GAG
production, viable cell density, mRNA expression of col-
lagen types I and III, and tenascin-C, and collagen-based
matrix production, confirming the positive benefit of the
microporous silk sponge. However, no significant differ-
ences in maximum tensile load or stiffness were recorded
compared to unseeded scaffolds after 14 days, suggesting
that the secreted matrix did not contribute towards scaf-
fold strength. Also, the tensile strength and stiffness were
far below (<20%) those of the adult human ACL [52],
which was their target tissue. Nevertheless, the cytocom-
patability and rapid T/L-like matrix development is
impressive and further demonstrates the effectiveness of
a cyto-friendly composite structure.
In addition to composite synthetic scaffolds, compo-
site natural scaffolds have also been fabricated for T/L
tissue engineering applications [53]. In this work a
knitted silk fibroin base matrix was infiltrated with a
freeze-dried collagen type I microsponge. MSC-seeded
scaffolds were implanted into a rabbit medial cruciate
ligament (MCL) transection model to evaluate in vivo
repair potential over 12 weeks. In vitro, the authors
found that gene expression levels of T/L-associated
genes by cells seeded in silk-collagen scaffolds compared
to silk alone were substantially higher, and showed col-
lagen type I elevated by 250% and decorin elevated by
over 500%. Furthermore, histological analysis with H&E
and Masson’s trichrome staining of the repairing MCL
found more tissue ingrowth compared to silk alone and
untreated MCLs after 2, 4, and 12 weeks (Fig. 2). These
results suggest that a chimeric silk-collagen sponge
matrix may be an effective treatment for MCL transec-
tions due to its rapid tissue ingrowth and favorable
genetic expression results. Optimization of sponge pore
size may be an important advancement in the develop-
ment of these engineered T/L scaffolds.
One of the most important evaluation tests in T/L
engineering is the success of an engineered graft to be
regenerated by the body into functional T/L. Recent
long-term studies by Fan et al. have investigated silk
scaffold T/L regeneration in rabbit [54] and pig models
[55], providing new insights into the kinetics of T/L tis-
sue ingrowth and scaffold degradation. First, a rabbit
ACL reconstruction model [54] was tested by transect-
ing healthy rabbit ACLs and surgically implanting an
MSC-seeded knitted silk scaffold with microporous silk
sponge into bone tunnels of rabbit knees. A morpholo-
gical and histological evaluation of implanted silk grafts
replacing the rabbit ACL after 8 weeks suggested sub-
stantial production of collagen type I, collagen type III,
and tenascin-C, and that the ligament-bone attachment
was stable (evaluated with micro-CT). However, similar
to other studies with knitted silk scaffolds the tensile
strength and stiffness were unfortunately well below
those of native human ACL. A subsequent study using
the larger porcine model showed similar, encouraging
results. To compensate for the additional load bearing,
the knitted-sponge silk scaffold was rolled around a
braided silk cord and again seeded with MSCs. After
24 weeks the gross morphological and histological char-
acteristics were evaluated and as before, collagen type I,
collagen type III, and tenascin-C were all distinctly pre-
sent as shown by immunohistochemistry analysis. How-
ever, with an average failure load of 398 N, the authors
noted that regenerated scaffolds at 24 weeks could be
effective for mild daily load bearing, but would likely
not survive trauma or vigorous exercise. Unfortunately
the scaffold strength at earlier time points was not mea-
sured; it is clear however that 24 weeks would likely be
too long for most patients to wait before mild load bear-
ing would be feasible. Nevertheless the clinical implica-
tions of this study are profound, and demonstrate the
in vivo effectiveness of a multi-structural silk scaffold
for T/L tissue engineering.
Because of their inherent biocompatibility, natural
polymeric macromolecules will remain at the forefront
of biomaterials research for T/L tissue engineering.
Although collagen type I gels may eventually be the
scaffold material to use, their ultimate tensile strengths
and elastic moduli are currently too low to act as a load
bearing material. In the interim, silk fibroin has emerged
as an excellent natural biomaterial alternative to col-
lagen and has already been shown to regenerate T/L in
large scale animal models. Assuming the success of
longer-term animal trials, it is anticipated that impend-
ing clinical trials with silk fibroin-based engineered liga-
ments will confirm the efficacy of silk to restore T/L
function after injury and offer an exciting new option
for T/L repair.
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Advanced scaffolds and signaling factors in ligament
tissue engineering
A. Functionalized T/L scaffolds
One of the key factors in effective application of mate-
rial scaffolds in tissue engineering is the optimization of
cell-biomaterial interactions, particularly in terms of the
ability of cells to adhere, proliferate, and secrete matrix
onto the scaffold. Synthetic and natural polymers are
effectively long chains of repeating chemical units, and
it is thus possible to link small molecules covalently to
their surfaces to enhance cell adhesion, proliferation,
and matrix production. Such an approach has high
Figure 2 Histological and gene expression analysis of the extent of in vivo repair after 14 days using silk and silk/collagen scaffolds in
a rabbit model of MCL transection [53]. (A, B) H&E staining showed relatively unorganized matrix formation but a high cell density in silk/
collagen scaffolds than silk alone. (C, D) Masson’s trichrome staining revealed the beginnings of collagen fiber formation (indicated by blue
areas), and more collagen deposition in the silk/collagen scaffold group. (E) Total collagen content was reduced in the silk/collagen group (S +
C), but, as detected by RT-PCR shown in (F, G), this could have been due to a reduction in the expression of collagen type III, an alternative
collagen type for the ligamentous phenotype than collagen type I and decorin, both of which showing higher level of expression in the silk/
collagen scaffold group. Reproduced with permission from Elsevier B.V.
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potential, since biomaterials that natively lack chemical
cell attachment groups can also be functionalized, thus
expanding the range of implantable biomaterials. Cell-
matrix interactions are typically mediated via cell surface
integrin receptors, which are specialized transmembrane
proteins that are connected cytoplasmically to the actin
cytoskeleton. The most common example of an integ-
rin-interacting matrix epitope is the peptide sequence,
RGD (arginine-glycine-aspartic acid) [56], which has
been used to functionalize a number of biomaterials.
The practice of functionalizing grafts to improve engi-
neered tissues is sometimes done passively by merging
one scaffold with another, for the purpose of combining
mechanical properties with integrin binding capability.
An example of passive functionalization is a recent work
by Garcia-Fuentes et al. [57] who blended hyaluronan, a
common native glycosaminoglycan, with silk fibroin and
seeded MSCs for general regenerative applications. Mat-
sumura et al. [58] conducted a more direct functionali-
zation study and modified poly(ethylene-co-vinyl
alcohol) (PEVA) films with carboxyl groups (COOH)
and subsequently covalently attached collagen type I,
designed to enhance periodontal ligament adhesion to
PEVA-coated titanium dental implants. Other general
tissue engineering applications have used a variety of
functionalizing groups including phosphate, amide and
sulfonate groups.
There has been some interest in adding functional
groups to non-degradable synthetic graft surfaces in the
hopes of enabling tissue growth and avoiding poor tis-
sue integration, foreign body immune responses, and
high failure rates. Zhou et al. [59] recently functiona-
lized polyethylene terephthalate (PET) grafts with poly
(sodium styrene sulfonate) (PNaSS) functional groups
and observed fibroblastic cell response. These investiga-
tors functionalized PET by first exposing PET fabrics to
ozone gas (O3), which is unstable and breaks into O2
and O•, the latter of which transfers its free radical to
the PET surface making it much more reactive. Under
an inert argon atmosphere, the samples were then
immersed in a bath of monomer 15% (w/v) sodium
p-(styrene sulfonate) (NaSS) at 65-70°C temperature,
forming polyNaSS on the PET surface by radical poly-
merization. The human fibroblast McCoy cell line was
seeded onto the functionalized PET surface and
observed after 4 days of culture with the live-cell fluor-
escence label calcein AM. Captured images revealed
considerably more cell adherence onto functionalized
fibers than non-functionalized fibers. Additionally,
dynamic fluid testing indicated that cells adhered to
polyNaSS-PET scaffolds compared to PET alone
required 12-fold more shear stress for 50% of adhered
cells to be removed (12 dyn/cm2 compared to 1 dyn/cm2).
The authors attributed these profound results to two
factors: the enhanced surface hydrophilicity enabling
cell spreading, and the opportunity for fibronectin to
bind to the PNaSS, increasing the number of focal
adhesion contacts and the potential for organized
cytoskeletal formation. It will be particularly interesting
when these functionalized grafts are implanted in vivo
to test if the foreign body capsulation response still
occurs, and if not, how they perform over long term
implantation.
B. Decellularized T/L scaffolds
It has been argued that the best replacement biomater-
ials for T/L are those derived from the T/L themselves
(when they are available) because the tissues already
have similar mechanical properties and because the
endogenous integrin binding sites are present and abun-
dant in the native ECM. However, some studies have
suggested that allograft tissues can contain residual
donor cells even with strict sterilization and cleaning
[60], and may cause a significant inflammatory response
when implanted in vivo [61]. Furthermore, there are
concerns about the extent and efficiency of cellular infil-
tration particularly to the dense center areas of the
graft. Thus, the application of chemical treatments to
yield a fully decellularized and more porous scaffold, as
opposed to the use of minimally treated allografts [62],
is preferred for T/L tissue engineering. Whitlock et al.
[63] recently addressed this issue with a novel oxidative
chemical treatment and a battery of in vitro cytocompat-
ibility and tissue tests. The authors isolated adult
chicken flexor digitorum profundus tendons and added
1.5% peracetic acid to act as an oxidizing agent (using
OH radicals) to create pores in the tissue and remove
loose DNA. Simultaneously, the detergent Triton X-100
(polyethylene glycol octylphenyl ether) was also added at
2% concentration to lyse cell membranes. When com-
pared to non-treated controls, the oxidized scaffolds had
no nuclei visibly present (H&E, DAPI staining) and at
minimum 70% less total DNA, which was considered a
promising result. The scaffolds also appeared more por-
ous, and on average had 25% less elastic modulus and
stiffness (p > 0.05). Results from a subcutaneous rat
in vivo cell infiltration study showed that after 3 weeks,
cells with nuclei were present in the outside layers and
some inner layers of the scaffold, and that no inflamma-
tory reaction or capsule formation was present. Future
studies with human T/L allografts utilizing a combina-
tion of a lysing agent and oxidiative agent are warranted,
and these treatments may prove to be effective in mini-
mizing the foreign body and capsulation responses
found with standard allografts.
C. Effects of growth factors on natural and engineered
tendons and ligaments
One of the most promising strategies to augment nat-
ural regeneration is the introduction of growth factors
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with specific activities on target tissues. Of the many
growth factors in the body, the following five growth
factors have shown promise for T/L engineering due to
their notable upregulation during T/L healing [64]: insu-
lin-like growth factor-I (IGF-I), transforming growth fac-
tor-b (TGF-b), vascular endothelial growth factor
(VEGF), platelet-derived growth factor (PDGF), and
basic fibroblastic growth factor (bFGF). Once considered
impractical due to their extremely high costs, growth
factors have recently been re-evaluated for their possible
application for T/L tissue engineering [65-68], made
possible by biotechnological advancements in the pro-
duction and purification of recombinant proteins. Of
these five growth factors, bFGF has shown particular
efficacy and has been known as an effective promoter of
T/L regeneration since early wound healing studies of
canine dental defects [69], and is now beginning to be
incorporated into full T/L tissue engineering strategies.
Sahoo et al. [70] blended bFGF with PLGA and pro-
duced electrospun nanofibrous scaffolds capable of
releasing 60% of the growth factor over the course of
one week. When these scaffolds were seeded with bone-
marrow derived rabbit MSCs and compared against
scaffolds without bFGF, the authors found significant
increases in cell proliferation, immunostaining of tenas-
cin-C and collagen types I and III, and gene expression
levels of collagen types I and III, fibronectin, and bigly-
can over 14 days, which are all promising indicators of
enhanced T/L differentiation. Impressively, these results
were attained with a bFGF concentration of only 11 μg/
mL of PLGA (dissolved in hexafluoroisopropanol).
Recently, bFGF was also employed in vivo in a rabbit
ACL repair model via loading into gelatin hydrogels to
form a three-part engineered ligament consisting of a
braided fibronectin-coated PLLA core, a collagen mem-
brane wrapping sheet, and the bFGF-loaded gelatin
hydrogels [71]. Observation at 8 weeks post-implanta-
tion revealed that the addition of bFGF increased both
the maximal strength and stiffness of the regenerated
ACL by approximately 50%, increased collagen mass in
the regenerated tissue by 2.5-4 fold, and produced histo-
logical cross-sections that more closely resembled native
ligament. This study demonstrates that local and con-
trolled release of growth factors such as bFGF can be
potent accelerators of T/L regeneration in vivo.
In addition to bFGF, TGF-b has also been implicated
as an important growth factor in T/L development, and
is actively being investigated for applications in T/L tis-
sue engineering. We characterized the spatiotemporal
distribution of TGF-b in the developing chick tendon
during embryonic days 13-16 (Fig. 3; [72]). Histologic
results demonstrated rapid tissue organization and
development during this time period. Immunohisto-
chemical staining showed TGF-b2 and -b3, but not
TGF-b1, were present within the tendon mid-substance
on all days studied. TGF-b2 and -b3 exhibited similar
distribution patterns, but differed in timing and inten-
sity. Taken together, these findings strongly support the
postulate that TGF-b2 and -b3 are involved in tendon
development and that these isoforms may have indepen-
dent roles. This was recently confirmed when TGF-b2
and -b3 knockout mice were unable to form most ten-
don and ligaments, and both TGF-b2 and -b3 were
shown to be essential for maintenance of tendon
progenitor cells in vivo[73]. In the near future, as pro-
duction of purified growth factor continues to become
more economical, more research on regenerative growth
factors will be performed, leading to information that
will guide the use of growth factors as integral compo-
nents of functional T/L replacement tissues.
D. Effects of cyclic strain on engineered ligaments
It is well known that locomotion induces tensile strain
on T/L tissues, and for more than 100 years [74] it has
been theorized and later demonstrated that the density
and remodeling of bone is related to its loading state
[75,76]. Thus it should be no surprise that since nearly
the inception of the field, tissue engineers have studied
the effect of forces on fibroblasts [77] and later on ACL
cells [78]. Subsequent to these preliminary experiments,
more elaborate bioreactors with uniaxial or multi-axial
applied forces were developed for musculoskeletal tissue
engineering. Altman et al. [79] developed a novel cyclic
strain bioreactor that simultaneously applied 10% tensile
strain and 25% torsional strain to MSC-seeded collagen
type I gels, designed to mimic the natural 90° twist on
ACL collagen fibers during knee flexion/extension. The
stimulation was applied at a rate of 0.0167 Hz for up to
21 days. Compared to static construct controls, the
mechanically stimulated gels had significantly higher
cross-sectional cell density and a 2.5-fold increase in cell
alignment. The most striking finding was that the
mRNA expression of collagen type I, collagen type III,
and tenascin-C in mechanically stimulated gels were all
significantly upregulated compared to static controls
and approached native T/L expression, and that bone
and cartilage markers were not upregulated. This was
the first study to demonstrate that MSCs could begin to
be differentiated into T/L-like lineages using mechanical
stimulation alone. The application of cyclic strain in
stem cell based bioreactor systems to promote cell pro-
liferation, cell alignment, and T/L-marker expression is
now an accepted and widely utilized method in T/L
tissue engineering [80]. This and other studies have
demonstrated enhanced matrix production by MSCs
when cyclically loaded under uniaxial tension in long-
term cultures, but have not elucidated the mechanisms
for these results [81-84]. To investigate potential
mechanisms, we conducted short term studies with
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Figure 3 Histology of transverse sections of intermediate tendon of chick embryos at developmental days 13, 14, 15, and 16 [72].
(Top) Hematoxylin-eosin staining; (Bottom) Mallory’s trichrome staining. Low magnification, Bar = 200 μm; high magnification, Bar = 50 μm.
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human MSCs in a similar model system utilizing col-
lagen type I scaffolds and uniaxial tensile loading, and
investigated putative tendon marker expression [85].
Results showed that while static uniaxial tensile loads
upregulated scleraxis expression, cyclic loading signifi-
cantly enhanced collagen matrix production (Fig. 4).
Cyclic loading was necessary to sustain mRNA levels of
scleraxis, a tendon-specific marker gene, and differen-
tially regulated additional developmental and mature
tendon marker molecules, including collagens, Wnts
and MMPs. The results of this study supported the pre-
mise that dynamic mechanical loading enhances teno-
genesis of hMSCs and provided insights into the
mechanisms of this process.
Synthetic biomaterials have also been implemented in
cyclic strain bioreactors for T/L tissue engineering. Moe
et al. [86] seeded human dermal fibroblasts on PLGA
10:90 knitted scaffolds and applied 1.8% tensile strain for
4 hours daily over two weeks at either static, 0.1 Hz or 1
Hz strain rates. Using H&E staining the authors found
the most substantial cellular alignment with a 0.1 Hz
applied strain rate; however, the scaffold stiffness of
mechanically stimulated constructs was significantly less
than that of static controls. However, the stiffness was
not normalized to cross-sectional area (i.e. elastic modu-
lus), and it is thus difficult to know if cell contraction
and/or matrix formation were partially responsible for
this result. Raif and Seedhom [87] also seeded cells onto
a knitted scaffold, but used non-degradable PET fibers
and bovine synovial cells, which appear to have the capa-
city to be de-differentiated into multipotent cells [88].
The applied strain parameters varied considerably
between 0.65-4.5% strain magnitude at 1 Hz and was
applied for 1-4 hours per day for either 1 or 35 days. The
authors found that cell proliferation during short-term
application was reduced at 1 hour post-stimulation, but
was upregulated 22 hours later. Furthermore, cell prolif-
eration increased as cyclic strain amplitude was
increased, suggesting a higher affinity for differentiation
or matrix production at lower strain amplitude, or simply
less cell proliferation. The long term (35-day) study did
not find significant differences except that higher strains
tended to result in a higher scaffold cellular density.
In addition to mechanical stimulation, recent studies
have investigated the combinatorial effect of mechanical
stimulation and cellular alignment. The developing
Figure 4 Histology of MSC-collagen constructs harvested after 1 and 7 days of static and cyclic loading [85]. Longitudinal 5-μm-thick
sections histologically stained with Mallory’s trichrome. A higher level of matrix staining is seen consistently in constructs subjected to cyclic
loading.
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underlying theory of the influence of patterned scaffold
structures is known as ‘contact guidance’, which states
that cellular response, especially alignment and prolif-
eration, is dependent on the size and type of the chan-
neling structure. Mechanically stimulating ACL cells
seeded on polydimethylsiloxane (PDMS) micropatterned
surfaces with an applied 8% uniaxial strain at 0.5 Hz for
4 hours a day and 2 days revealed the expression of sev-
eral novel genes influenced by mechanical stimulation
[89]. Specifically, microarray-based real-time PCR analy-
sis showed that expression of the following genes
decreased during normal culture but increased after
mechanical stimulation: MGP (matrix Gla-protein,
3.8-fold), GADD45A (growth arrest and DNA damage-
inducible gene, 2.3-fold), UNC5B (unc-5 homolog B,
1.6-fold), TGFB1 (transforming growth factor-b1,
1.4-fold), COL4A1 (collagen type IV a1, 1.2-fold), and
COL4A2 (collagen type IV a2, 1.2-fold). The authors
noted that MGP is a small matrix protein that may be
involved in cellular differentiation, and that GADD45A
may influence cell cycle proteins and play a role in
genomic stability. The exact functions of some of these
genes in T/L biology are not well understood and
certainly warrant further investigation, especially with
other cell types. In a similar study, Jones et al. [90]
seeded rat MCL cells on a microgrooved PDMS sub-
strate and applied 3.5% strain at 1 Hz for 2 hours. The
authors found considerably more alignment in the
groove and stretch direction compared to cells grown
on a smooth PDMS surface (Fig. 5), and that intercellu-
lar propagation of mechanically induced Ca2+ flux was
significantly enhanced with the application of cyclic
Figure 5 Fluorescence images of actin filaments (red) and nuclei (blue) of MCL fibroblasts cultured on collagen-coated PDMS surfaces
[90]. (Left column) Cells cultured on smooth PDMS substrates showed randomly aligned cytoskeletal and nuclear morphology, even after 3.5%
cyclic strain at 1 Hz for 2 hours (c). (Right column) Cells cultured in PDMS microgrooves with 10 μm width and 6 μm depth were substantially
more aligned, based on cytoskeletal and nuclear morphology, compared to smooth PDMS, especially after being cyclically strained (d). (e, f)
Control cells grown in the custom cyclic strain incubator without strain applied showed similar results to cells cultured in a standard incubator
(a, b). Reproduced with permission from Elsevier B.V.
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strain (p < 0.001), but not when grooves alone were
introduced. Taken together, these findings suggest that
uniaxial mechanical stimulation and not only forced
cellular alignment is necessary to produce positive bene-
fits for T/L tissue engineering.
While mechanical stimulation is a relatively new prac-
tice in tissue engineering, it is actively being employed
to develop a variety of musculoskeletal engineered tis-
sues, including tendon, ligament, muscle, and bone con-
structs. In most if not all cases, the addition of cyclic
strain has conferred a positive benefit especially with
cell proliferation, density, and differentiation of stem
cells towards musculoskeletal lineages. However, one
important admonition is that the ideal mechanical
stimulation regime is far from being described, and spe-
cific biological models of mechanical stimulation to
tissues are lacking. Thus, given the excellent cost-benefit
ratio of applying mechanical stimulation, there is a need
for further optimization of applied tissue strains with
T/L tissue systems, and perhaps in the future applying
an optimized mechanical stimulation regime to engi-
neered T/L will be commonplace.
Conclusions
The field of T/L tissue engineering is progressing at an
increasingly rapid pace; in just 10 years engineered
tendons and ligaments have advanced from concept to
capable of regenerating large animal ligaments in long
term studies. The potential health care implications of
engineered T/L are extensive and with an aging popula-
tion will become more important with time.
The design factors for T/L engineering have thus far
included: native T/L anatomy, biomaterial mechanical
properties, biomaterial degradation rate, cellular adher-
ence/spreading on biomaterials, and matrix formation.
From a biomaterials perspective, it is clear that match-
ing biomaterial properties to the native T/L structure
and function is a critical consideration. Yet what has
also been important for the progression of the field has
been the utilization of combinatorial approaches; exam-
ples of this include merging braided scaffolds with
sponges, merging two materials into a single scaffold,
functionalizing a biodegradable surface, or adding
mechanical stimulation to aligned cells. In all cases
there is not one superior engineered T/L design, and
thus far the ideal engineered tendon or ligament has yet
to be created. Some of the important future milestones
of T/L tissue engineering include improving the strength
and biological integrity of the tendon-muscle and ten-
don/ligament-bone junctions of implanted engineered
T/L, developing scaffolds and models that match the
rate of scaffold degradation with the rate of tissue
ingrowth, matching native T/L elastic and viscoelastic
mechanical properties, and developing T/L disease
models through tissue engineering. Meeting the
demands of these requirements will require concen-
trated interdisciplinary efforts from biologists, chemists,
biomaterials scientists and tissue engineers, which will
eventually provide a new and improved option for repair
of injured tendons and ligaments to thousands of
patients in need of help.
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